Correlation Between Replimune and Mineralys Therapeutics,
Can any of the company-specific risk be diversified away by investing in both Replimune and Mineralys Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Replimune and Mineralys Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Replimune Group and Mineralys Therapeutics, Common, you can compare the effects of market volatilities on Replimune and Mineralys Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Replimune with a short position of Mineralys Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Replimune and Mineralys Therapeutics,.
Diversification Opportunities for Replimune and Mineralys Therapeutics,
0.57 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Replimune and Mineralys is 0.57. Overlapping area represents the amount of risk that can be diversified away by holding Replimune Group and Mineralys Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mineralys Therapeutics, and Replimune is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Replimune Group are associated (or correlated) with Mineralys Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mineralys Therapeutics, has no effect on the direction of Replimune i.e., Replimune and Mineralys Therapeutics, go up and down completely randomly.
Pair Corralation between Replimune and Mineralys Therapeutics,
Given the investment horizon of 90 days Replimune Group is expected to generate 1.58 times more return on investment than Mineralys Therapeutics,. However, Replimune is 1.58 times more volatile than Mineralys Therapeutics, Common. It trades about 0.13 of its potential returns per unit of risk. Mineralys Therapeutics, Common is currently generating about -0.06 per unit of risk. If you would invest 1,205 in Replimune Group on August 29, 2024 and sell it today you would earn a total of 233.00 from holding Replimune Group or generate 19.34% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Replimune Group vs. Mineralys Therapeutics, Common
Performance |
| Timeline |
| Replimune Group |
| Mineralys Therapeutics, |
Replimune and Mineralys Therapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Replimune and Mineralys Therapeutics,
The main advantage of trading using opposite Replimune and Mineralys Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Replimune position performs unexpectedly, Mineralys Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mineralys Therapeutics, will offset losses from the drop in Mineralys Therapeutics,'s long position.| Replimune vs. Eliem Therapeutics | Replimune vs. Scpharmaceuticals | Replimune vs. Milestone Pharmaceuticals | Replimune vs. Seres Therapeutics |
| Mineralys Therapeutics, vs. Eliem Therapeutics | Mineralys Therapeutics, vs. Scpharmaceuticals | Mineralys Therapeutics, vs. Milestone Pharmaceuticals | Mineralys Therapeutics, vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |